Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-11-13 00:15 | 2020-11-09 | CWH | Camping World Holdings, Inc. | ADAMS STEPHEN | Director | Retail-Auto Dealers & Gasoline Stations | BUY | $24.55 | 200,000 | $4,909,600 | 200,000 | +100.0% |
| 2020-11-13 05:41 | 2020-11-10 | PI | IMPINJ INC | Sylebra Capital Ltd | Director, 10% owner | Electronic Components, NEC | BUY | $31.09 | 391,743 | $12,179,290 | 4,397,337 | +9.8% |
| 2020-11-13 00:45 | 2020-11-10 | UEPS | LESAKA TECHNOLOGIES INC | Ball Antony C | Director | Functions Related To Depository Banking, NEC | BUY | $3.12 | 583,345 | $1,820,036 | 10,738,310 | +5.7% |
| 2020-11-13 00:45 | 2020-11-10 | UEPS | LESAKA TECHNOLOGIES INC | Value Capital Partners (Pty) Ltd | 10% owner | Functions Related To Depository Banking, NEC | BUY | $3.12 | 583,345 | $1,820,036 | 10,738,310 | +5.7% |
| 2020-11-13 01:54 | 2020-11-09 | CERE | N/A | BAIN CAPITAL INVESTORS LLC | 10% owner | Other | BUY | $10.30 | 332,293 | $3,422,618 | 60,632,356 | +0.6% |
| 2020-11-11 01:01 | 2020-11-06 | XRX | Xerox Holdings Corp | ICAHN CARL C | 10% owner | Computer Peripheral Equipment, NEC | BUY | $18.99 | 243,198 | $4,618,330 | 28,769,235 | +0.9% |
| 2020-11-11 00:25 | 2020-11-06 | SMMT | Summit Therapeutics Inc. | DUGGAN ROBERT W | Director, Officer, 10% owner - Chief Executive Officer | Pharmaceutical Preparations | BUY | $3.34 | 14,071,856 | $46,999,999 | 56,296,533 | +33.3% |
| 2020-11-10 01:24 | 2020-11-09 | KHC | Kraft Heinz Co | Van Damme Alexandre | Director | Canned, Frozen & Preservd Fruit, Veg & Food Specialties | BUY | $30.38 | 13,849,315 | $420,742,190 | 14,099,315 | +5,539.7% |
| 2020-11-09 19:29 | 2020-11-05 | RDUS | N/A | BIOTECH TARGET N V | 10% owner | Other | BUY | $14.26 | 100,000 | $1,426,230 | 7,455,714 | +1.4% |
| 2020-11-10 00:09 | 2020-11-05 | MTEM | N/A | BIOTECH TARGET N V | 10% owner | Other | BUY | $8.68 | 545,335 | $4,734,217 | 5,775,331 | +10.4% |
| 2020-11-10 02:03 | 2020-11-05 | AON | Aon plc | KNIGHT LESTER B | Director | Insurance Agents, Brokers & Service | BUY | $186.55 | 10,000 | $1,865,526 | 10,000 | +100.0% |
| 2020-11-07 02:46 | 2020-10-30 | NVUS | Eledon Pharmaceuticals, Inc. | Logos Global Management LP | 10% owner | Pharmaceutical Preparations | BUY | $25.44 | 92,040 | $2,341,709 | 224,071 | +69.7% |
| 2020-11-07 00:32 | 2020-08-10 | ORTX | N/A | RA CAPITAL MANAGEMENT, L.P. | 10% owner | Other | BUY | $4.63 | 769,017 | $3,563,163 | 9,880,865 | +8.4% |
| 2020-11-06 20:48 | 2020-11-05 | GLQ | Clough Global Equity Fund | Clough Charles JR | Other | Other | BUY | $11.63 | 86,000 | $1,000,137 | 153,848 | +126.8% |
| 2020-11-07 00:39 | 2020-11-05 | AAT | American Assets Trust, Inc. | RADY ERNEST S | Director, Officer, 10% owner - Chairman, CEO & President | Real Estate Investment Trusts | BUY | $21.49 | 130,000 | $2,793,700 | 1,566,172 | +9.1% |
| 2020-11-07 03:05 | 2020-11-04 | BMRG | Eos Energy Enterprises, Inc. | B. Riley Financial, Inc. | 10% owner | Miscellaneous Electrical Machinery, Equipment & Supplies | BUY | $10.10 | 2,347,930 | $23,713,623 | 2,347,930 | +100.0% |
| 2020-11-07 00:47 | 2020-11-04 | APVO | Aptevo Therapeutics Inc. | TANG KEVIN C | 10% owner | Pharmaceutical Preparations | BUY | $17.30 | 1,436,675 | $24,849,162 | 1,760,000 | +444.3% |
| 2020-11-07 02:33 | 2020-11-04 | GLYC | CRESCENT BIOPHARMA, INC. | BVF PARTNERS L P/IL | 10% owner | Pharmaceutical Preparations | BUY | $2.60 | 1,266,737 | $3,293,516 | 630,453 | +100.0% |
| 2020-11-07 02:30 | 2020-11-04 | FPRX | N/A | BVF PARTNERS L P/IL | 10% owner | Other | BUY | $4.89 | 446,562 | $2,184,090 | 583,912 | +325.1% |
| 2020-11-06 00:47 | 2020-11-03 | XRX | Xerox Holdings Corp | ICAHN CARL C | 10% owner | Computer Peripheral Equipment, NEC | BUY | $18.35 | 1,060,010 | $19,456,272 | 28,526,037 | +3.9% |
| 2020-11-06 02:11 | 2020-11-03 | RILY | BRC Group Holdings, Inc. | RILEY BRYANT R | Director, Officer, 10% owner - Chairman and Co-CEO | Investment Advice | BUY | $26.66 | 141,728 | $3,778,213 | 317,915 | +80.4% |
| 2020-11-06 02:08 | 2020-11-03 | SQZ | N/A | Temasek Holdings (Private) Ltd | 10% owner | Other | BUY | $16.00 | 625,000 | $10,000,000 | 2,513,924 | +33.1% |
| 2020-11-05 04:00 | 2020-11-02 | GLTO | Galecto, Inc. | Khuong Chau Quang | Director, 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 733,333 | $10,999,995 | 1,031,811 | +245.7% |
| 2020-11-05 00:49 | 2020-11-03 | SQZ | N/A | AMERICAN INTERNATIONAL GROUP INC | 10% owner | Other | BUY | $16.00 | 625,000 | $10,000,000 | 625,000 | +100.0% |
| 2020-11-05 00:05 | 2020-11-03 | AVIR | Atea Pharmaceuticals, Inc. | Rock Springs Capital Management LP | 10% owner | Pharmaceutical Preparations | BUY | $24.00 | 250,000 | $6,000,000 | 289,695 | +629.8% |
| 2020-11-04 18:37 | 2020-11-02 | VTA | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $9.28 | 591,780 | $5,490,890 | 7,671,902 | +8.4% |
| 2020-11-05 03:52 | 2020-11-02 | GLTO | Galecto, Inc. | Novo Holdings A/S | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 333,333 | $4,999,995 | 2,497,791 | +15.4% |
| 2020-11-05 00:46 | 2020-11-02 | RADI | N/A | DKLDO IV Trading Subsidiary LP | 10% owner | Other | BUY | $7.75 | 478,629 | $3,708,992 | 7,581,530 | +6.7% |
| 2020-11-05 00:37 | 2020-11-03 | ESPR | Esperion Therapeutics, Inc. | BIOTECH TARGET N V | 10% owner | Pharmaceutical Preparations | BUY | $25.31 | 200,000 | $5,062,120 | 3,947,964 | +5.3% |
| 2020-11-05 00:51 | 2020-11-02 | AAT | American Assets Trust, Inc. | RADY ERNEST S | Director, Officer, 10% owner - Chairman, CEO & President | Real Estate Investment Trusts | BUY | $21.64 | 175,739 | $3,802,939 | 1,436,172 | +13.9% |
| 2020-11-04 23:05 | 2020-10-28 | MTEM | N/A | BIOTECH TARGET N V | 10% owner | Other | BUY | $9.11 | 160,000 | $1,458,000 | 5,229,996 | +3.2% |
| 2020-11-05 04:00 | 2020-11-02 | GLTO | Galecto, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 733,333 | $10,999,995 | 1,031,811 | +245.7% |
| 2020-11-04 04:00 | 2020-11-03 | SQZ | N/A | Polaris Management Co. VII, L.L.C. | 10% owner | Other | BUY | $16.00 | 250,000 | $4,000,000 | 2,549,306 | +10.9% |
| 2020-11-04 05:36 | 2020-11-03 | AVIR | Atea Pharmaceuticals, Inc. | Hack Andrew A. F. | Director | Pharmaceutical Preparations | BUY | $24.00 | 250,000 | $6,000,000 | 5,615,659 | +4.7% |
| 2020-11-04 01:59 | 2020-10-30 | ROOT | Root, Inc. | Malka Meyer | 10% owner | Fire, Marine & Casualty Insurance | BUY | $27.00 | 1,000,000 | $27,000,000 | 1,000,000 | +100.0% |
| 2020-11-04 04:00 | 2020-11-03 | SQZ | N/A | SCHULMAN AMY W | Director, 10% owner | Other | BUY | $16.00 | 250,000 | $4,000,000 | 2,549,306 | +10.9% |
| 2020-11-04 02:24 | 2020-10-30 | BDSX | BIODESIX INC | Strobeck Matthew | Director | Services-Medical Laboratories | BUY | $18.00 | 83,333 | $1,499,994 | 83,333 | +100.0% |
| 2020-11-04 03:56 | 2020-10-30 | KALV | KalVista Pharmaceuticals, Inc. | Cha Albert | Director | Pharmaceutical Preparations | BUY | $17.24 | 115,686 | $1,994,068 | 1,138,179 | +11.3% |
| 2020-11-03 23:14 | 2020-11-03 | RILY | BRC Group Holdings, Inc. | PAULSON RANDALL E | Director | Investment Advice | BUY | $26.65 | 40,000 | $1,066,008 | 78,343 | +104.3% |
| 2020-11-03 23:13 | 2020-11-03 | RILY | BRC Group Holdings, Inc. | RILEY BRYANT R | Director, Officer, 10% owner - Chairman and Co-CEO | Investment Advice | BUY | $26.66 | 60,000 | $1,599,510 | 4,734,165 | +1.3% |
| 2020-11-04 02:14 | 2020-10-30 | SAFT | SAFETY INSURANCE GROUP INC | SRB Corp | 10% owner | Fire, Marine & Casualty Insurance | BUY | $69.91 | 43,378 | $3,032,712 | 1,674,132 | +2.7% |
| 2020-11-03 21:21 | 2020-11-02 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | WALLMAN RICHARD F | Director | Services-Commercial Physical & Biological Research | BUY | $233.20 | 7,200 | $1,679,006 | 6,050 | +100.0% |
| 2020-11-03 23:05 | 2020-11-02 | RGCO | RGC RESOURCES INC | AGEE NANCY H | Director | Natural Gas Transmisison & Distribution | BUY | $23.88 | 62,814 | $1,499,998 | 38,278 | +100.0% |
| 2020-11-04 00:44 | 2020-10-30 | GLYC | CRESCENT BIOPHARMA, INC. | BVF PARTNERS L P/IL | 10% owner | Pharmaceutical Preparations | BUY | $2.75 | 932,612 | $2,564,683 | 544,363 | +100.0% |
| 2020-11-04 04:00 | 2020-11-03 | SQZ | N/A | Invus Public Equities, L.P. | 10% owner | Other | BUY | $16.00 | 465,000 | $7,440,000 | 1,606,308 | +40.7% |
| 2020-11-03 23:56 | 2020-10-30 | BIF | SRH Total Return Fund, Inc. | SUSAN L CICIORA TRUST | 10% owner | Other | BUY | $6.56 | 15,690,062 | $102,994,274 | 23,349,382 | +204.8% |
| 2020-11-04 00:15 | 2020-10-30 | BIF | SRH Total Return Fund, Inc. | STEWART WEST INDIES TRUST | 10% owner | Other | BUY | $6.56 | 15,101,049 | $99,127,816 | 16,900,168 | +839.4% |
| 2020-11-04 02:21 | 2020-10-30 | BDSX | BIODESIX INC | SCHULER JACK W | Director, 10% owner | Services-Medical Laboratories | BUY | $18.00 | 277,777 | $4,999,986 | 277,777 | +100.0% |
| 2020-11-03 00:18 | 2020-11-02 | XCSIX | N/A | Pickering Matthew | Other | Other | BUY | $20.00 | 75,000 | $1,500,000 | 75,000 | +100.0% |
| 2020-11-03 00:17 | 2020-11-02 | XCSIX | N/A | Clark Chad | Other | Other | BUY | $20.00 | 630,000 | $12,600,000 | 630,000 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.